albi

Bibliographie | CBP

Cirrhose Biliaire Primitive

CBP : une fausse réputation de bénignité
Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW.
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis : follow-up for up to 28 years
Gastroenterology 2002; 123 :1044-1051

CBP et carcinome hépatocellulaire : une complicationnon exceptionnelle
Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J.
Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis
Am J Gastroenterol 2001; 96 :1160-1163

Overlap syndrome : est-ce plus grave ?
Joshi S, Cauch-Dudek K, Wanless I, Lindor K, Jorgensen R, Batts K, HeathcoteEJ.
Primary biliary cirrhosis with additional features of autoimmune hepatitis : response to therapy with ursodeoxycholic acidHepatology 2002; 35 :409-413Chazouillères O, Poupon R.
Ursodeoxycholic acid and primary biliary cirrhosis with additional features of autoimmune hepatitis
Hepatology 2002; 36 :1026-1027

L’AUDC freine la progression de la fibrose hépatiqueau cours de la CBP
Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R.
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
Hepatology 2000; 32 :1196-1199.

CBP et pronostic histologique: incidence et facteursprédictifsde développement de la cirrhose sous AUDC
Corpechot C, Carrat F, Poupon R, Poupon RE.
Primary biliary cirrhosis : incidence and predictive factors of cirrhosis development in ursodiol-treated patients
Gastroenterology 2002; 122 :652-658.

Acide ursodésoxycholique : la polémique (meta-analyseou analyse combinée des données individuelles ?)
Goulis J, Leandro G, Burroughs A.
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis : a meta-analysisLancet 1999; 354 :1053-1060Lindor K, Poupon R, Poupon RE, Heathcote EJ, Therneau T.
Ursodeoxycholic acid for primary biliary cirrhosis
Lancet 2000; 355 :657-658

CBP et corticoïdes : une question de timing?
Leuschner M, Maier KP, Schlichting J, Strahl S, Herrmann G, Dahm HH,Ackermann H, Happ J, Leuschner U.
Oral budesonide and ursodeoxycholic acid treatment of primary biliary cirrhosis : results of a prospective bouble-blind trial.
Gastroenterology 1999; 117 :918-925

Angulo P, Jorgensen RA, Keach JC, Dickson ER, Smith C, Lindor K.
Oral budesonide in the treatment of patients with primary biliary cirrhosis with suboptimal response to ursodeoxycholic acid
Hepatology 2000; 31 :318-323

CBP et transplantation : 20 ans de recul
Liermann Garcia RF, Garcia CE, McMaster P, Neuberger J.
Transplantation for primary biliary cirrhosis : retrospective analysis of 400 patients in a single center
Hepatology 2001; 33 :22-27

Mots clés : CBP > Recherche
Page publiée le 16 novembre 2007 | Modifiée le 12 octobre 2009
Les commentaires sont fermés pour cet article, exprimez-vous sur le forum d'albi.